Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard D Chilcoat

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Addiction (Abingdon, England)|April 21, 2010
Social integration in young adulthood and the subsequent onset of substance use and disorders among a community population of urban African AmericansKerry M Green, Elaine E Doherty, Heather S Reisinger, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 24, 2003
Utility of TOCA-R scores during the elementary school years in identifying later violence among adolescent malesHanno Petras, Howard D Chilcoat, Philip J Leaf, et al.
Drug and Alcohol Dependence|April 12, 2014
The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusersJennifer R Havens, Carl G Leukefeld, Angela M DeVeaugh-Geiss, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2014
Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulationNelson E Sessler, Jerod M Downing, Hrishikesh Kale, et al.
Journal of Medical Internet Research|May 8, 2014
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuseEmily C McNaughton, Paul M Coplan, Ryan A Black, et al.
Journal of Medical Internet Research|April 25, 2025
Social Listening for Patient Experiences With Stopping Extended-Release Buprenorphine: Content Analysis of Reddit MessagesMichael K Gilbert, Ashlynn R Daughton, Howard D Chilcoat, et al.
BMC Pharmacology & Toxicology|May 15, 2016
Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent propertiesShannon L Janoff, Nancy A Perrin, Paul M Coplan, et al.
Pharmacoepidemiology and Drug Safety|January 12, 2017
Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death recordsCarla A Green, Nancy A Perrin, Shannon L Janoff, et al.
Drug and Alcohol Dependence|August 14, 2016
Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysisBobbi Jo H Yarborough, Scott P Stumbo, Shannon L Janoff, et al.
Journal of Substance Abuse Treatment|June 17, 2021
Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarcerationJan Gryczynski, Joshua D Lee, Kristi Dusek, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Addiction (Abingdon, England)|April 21, 2010
Social integration in young adulthood and the subsequent onset of substance use and disorders among a community population of urban African AmericansKerry M Green, Elaine E Doherty, Heather S Reisinger, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 24, 2003
Utility of TOCA-R scores during the elementary school years in identifying later violence among adolescent malesHanno Petras, Howard D Chilcoat, Philip J Leaf, et al.
Drug and Alcohol Dependence|April 12, 2014
The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusersJennifer R Havens, Carl G Leukefeld, Angela M DeVeaugh-Geiss, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2014
Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulationNelson E Sessler, Jerod M Downing, Hrishikesh Kale, et al.
Journal of Medical Internet Research|May 8, 2014
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuseEmily C McNaughton, Paul M Coplan, Ryan A Black, et al.
Journal of Medical Internet Research|April 25, 2025
Social Listening for Patient Experiences With Stopping Extended-Release Buprenorphine: Content Analysis of Reddit MessagesMichael K Gilbert, Ashlynn R Daughton, Howard D Chilcoat, et al.
BMC Pharmacology & Toxicology|May 15, 2016
Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent propertiesShannon L Janoff, Nancy A Perrin, Paul M Coplan, et al.
Pharmacoepidemiology and Drug Safety|January 12, 2017
Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death recordsCarla A Green, Nancy A Perrin, Shannon L Janoff, et al.
Drug and Alcohol Dependence|August 14, 2016
Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysisBobbi Jo H Yarborough, Scott P Stumbo, Shannon L Janoff, et al.
Journal of Substance Abuse Treatment|June 17, 2021
Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarcerationJan Gryczynski, Joshua D Lee, Kristi Dusek, et al.
Pageof 5